Uncategorized

European regulators greenlight Fractyl Health’s clinical test of GLP-1 gene therapy

Published

2 hours ago

on

Drug developers are racing to make gene therapies that could replace chronic GLP-1 injections and pills with a one-and-done treatment. Now, a company based just outside of Boston is poised to become …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version